Plain-English translation of NCT06076083 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is building a database to understand how gut bacteria (your microbiome) may be connected to ankylosing spondylitis, a condition that causes spine inflammation. Researchers will collect biological samples and health information from people living with this condition and their family members to study patterns that might explain why some people develop it and others don't.
Ankylosing spondylitis is a chronic inflammatory condition affecting the spine, but doctors don't yet fully understand what causes it or why it runs in families. Recent research suggests that the bacteria living in our digestive system may play a role, so this study aims to explore those connections and potentially discover new ways to understand and treat the disease.
You likely qualify if…
You likely don't qualify if…
You will provide biological samples (such as stool and saliva samples) using standardized collection protocols and complete questionnaires about your medical history, symptoms, and lifestyle. Researchers will then analyze these samples to study your gut bacteria and other biological markers, comparing patterns between people with the condition and family members without it. The study involves one or more visits to provide samples and information, with no ongoing medication or lifestyle changes required.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
South Korea
Sponsor
Tae-Hwan Kim
Collaborators
Kyunghee University Medical Center
Enrollment target
~600 participants
Started
October 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
19 Years – 60 Years
Last updated on clinicaltrials.gov in November 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tae-Hwan Kim, MD,PhD
Hanyang University Hospital for Rheumatic Diseases
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.